PHP
CNSY

Parkman Healthcare Partners’s Cerenome CNSY Stock Holding History

Parkman Healthcare Partners’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,556
Closed -$185K – 91
2022
Q4 		$185K Sell
1,556
-1,977
-56% -$315K 0.05% 79
2022
Q3 		$590K Sell
3,533
-555
-14% -$124K 0.17% 83
2022
Q2 		$828K Buy
4,088
+18
+0.4% +$4.5K 0.3% 62
2022
Q1 		$1.53M Buy
+4,070
New +$1.55M 0.45% 56

Other funds holding CNSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $6.33B AUM 25.27% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Parkman Healthcare Partners's CNSY Position: Q1 2023 in Review

Parkman Healthcare Partners sold out of Cerenome (CNSY) in Q1 2023, closing a stake of 1,556 shares — an estimated $185K sold.

Parkman Healthcare Partners first reported a position in CNSY in Q1 2022 and held it in 4 quarters. The position peaked at $1.53M in Q1 2022. 16 funds tracked by Wall St. Rank hold CNSY as of Q1 2023.

  • Parkman Healthcare Partners reported no remaining Cerenome position as of Q1 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 1,556 Cerenome shares in Q1 2023, an estimated $185K.
  • Parkman Healthcare Partners first reported a position in Cerenome in Q1 2022 and held it in 4 quarters.
  • Parkman Healthcare Partners's Cerenome position peaked at $1.53M in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Cerenome as of Q1 2023.

Based on Parkman Healthcare Partners's 13F filing for Q1 2023, filed 12 May 2023.